COX-2 plays an important role in the development of various types of cancer, including lung cancer (Sahin et al. 2009), and drugs targeting this enzyme have achieved widespread clinical use (Bertagnolli 2007). The gene discussed is PTGS2; the disease is lung carcinoma.